Craig Moskowitz, MD
University of Miami · Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Craig Moskowitz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:15 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05839210 · Lifestyle Intervention of Food and Exercise for Lymphoma SurvivorsUniversity of Miami · recruiting · Non Hodgkin Lymphoma, Hodgkin Lymphoma · principal investigator
- Ph2NCT04189952 · Acalabrutinib in Combination With R-ICE For Relapsed or Refractory LymphomaUniversity of Miami · terminated · Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia · principal investigator
- Ph2NCT00705250 · Bendamustine HCL in Relapsed and Primary Refractory Hodgkin LymphomaMemorial Sloan Kettering Cancer Center · completed · Hodgkin's Disease, Lymphoma · principal investigator
- Ph2NCT00588094 · Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHLMemorial Sloan Kettering Cancer Center · completed · Lymphoma, B-cell Non-Hodgkin's Lymphoma · principal investigator
- Ph2NCT00521014 · GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · principal investigator
- Ph1/Ph2NCT00441818 · Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's LymphomaTanox · unknown · Hodgkin's Lymphoma · principal investigator
- Ph2NCT00425802 · Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaMemorial Sloan Kettering Cancer Center · completed · Leukemia, Lymphoma · principal investigator
- Ph2NCT00255723 · Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · study chair
- Ph2NCT00005631 · Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · study chair
- Ph2NCT00002982 · Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · study chair
- Ph2NCT00039195 · Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · study chair
- Ph2NCT00002697 · Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaMemorial Sloan Kettering Cancer Center · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALEX MACDONALD · fiscal years 2011 to 2026Named on NCT00521014
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.